Northern Trust Corp Acadia Pharmaceuticals Inc Transaction History

Northern Trust Corp

  • $761 Billion
  • Q3 2025

A detailed history of Northern Trust Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,303,536 shares of ACAD stock, worth $31.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,303,536
Previous 1,302,616 0.07%
Holding current value
$31.3 Million
Previous $28.1 Million 1.0%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$20.88 - $26.57 $19,209 - $24,444
920 Added 0.07%
1,303,536 $27.8 Million
Q2 2025

Aug 13, 2025
SELL
$14.1 - $22.95 $1.02 Million - $1.67 Million
-72,597 Reduced 5.28%
1,302,616 $28.1 Million
Q1 2025

May 13, 2025
BUY
$16.61 - $20.29 $2.37 Million - $2.9 Million
142,847 Added 11.59%
1,375,213 $22.8 Million
Q4 2024

Feb 14, 2025
BUY
$14.29 - $18.76 $1.52 Million - $1.99 Million
106,236 Added 9.43%
1,232,366 $22.6 Million
Q3 2024

Nov 13, 2024
SELL
$15.14 - $19.14 $282,027 - $356,539
-18,628 Reduced 1.63%
1,126,130 $17.3 Million
Q2 2024

Aug 14, 2024
SELL
$14.62 - $18.42 $688,134 - $866,992
-47,068 Reduced 3.95%
1,144,758 $18.6 Million
Q1 2024

May 14, 2024
SELL
$17.79 - $30.86 $396,841 - $688,394
-22,307 Reduced 1.84%
1,191,826 $22 Million
Q4 2023

Feb 13, 2024
SELL
$20.78 - $31.77 $135,984 - $207,902
-6,544 Reduced 0.54%
1,214,133 $38 Million
Q3 2023

Nov 13, 2023
BUY
$20.84 - $33.47 $1.2 Million - $1.93 Million
57,555 Added 4.95%
1,220,677 $25.4 Million
Q2 2023

Aug 11, 2023
SELL
$17.8 - $25.65 $64,115 - $92,391
-3,602 Reduced 0.31%
1,163,122 $27.9 Million
Q1 2023

May 15, 2023
BUY
$16.32 - $20.92 $643,660 - $825,084
39,440 Added 3.5%
1,166,724 $22 Million
Q4 2022

Feb 13, 2023
BUY
$14.2 - $18.63 $146,899 - $192,727
10,345 Added 0.93%
1,127,284 $17.9 Million
Q3 2022

Nov 14, 2022
SELL
$14.11 - $18.27 $195,395 - $253,002
-13,848 Reduced 1.22%
1,116,939 $18.3 Million
Q2 2022

Aug 12, 2022
SELL
$13.01 - $27.22 $517,524 - $1.08 Million
-39,779 Reduced 3.4%
1,130,787 $15.9 Million
Q1 2022

May 13, 2022
SELL
$20.94 - $27.5 $1.13 Million - $1.49 Million
-54,096 Reduced 4.42%
1,170,566 $28.4 Million
Q4 2021

Feb 08, 2022
SELL
$16.79 - $27.09 $1.25 Million - $2.02 Million
-74,657 Reduced 5.75%
1,224,662 $28.6 Million
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $636,423 - $998,998
-40,331 Reduced 3.01%
1,299,319 $21.6 Million
Q2 2021

Aug 13, 2021
BUY
$19.4 - $27.42 $14.2 Million - $20.1 Million
733,652 Added 121.07%
1,339,650 $32.7 Million
Q1 2021

May 12, 2021
BUY
$25.02 - $54.99 $215,797 - $474,288
8,625 Added 1.44%
605,998 $15.6 Million
Q4 2020

Feb 11, 2021
BUY
$41.04 - $56.79 $389,469 - $538,937
9,490 Added 1.61%
597,373 $31.9 Million
Q3 2020

Nov 16, 2020
SELL
$36.42 - $57.0 $616,117 - $964,269
-16,917 Reduced 2.8%
587,883 $24.3 Million
Q2 2020

Aug 14, 2020
SELL
$39.26 - $52.73 $35 Million - $47.1 Million
-892,709 Reduced 59.61%
604,800 $29.3 Million
Q1 2020

May 14, 2020
BUY
$31.65 - $46.87 $695,951 - $1.03 Million
21,989 Added 1.49%
1,497,509 $63.3 Million
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $1.99 Million - $2.82 Million
54,925 Added 3.87%
1,475,520 $63.1 Million
Q3 2019

Nov 13, 2019
SELL
$22.22 - $44.01 $1.07 Million - $2.12 Million
-48,189 Reduced 3.28%
1,420,595 $51.1 Million
Q2 2019

Aug 13, 2019
SELL
$23.32 - $28.12 $416,541 - $502,279
-17,862 Reduced 1.2%
1,468,784 $39.3 Million
Q1 2019

May 13, 2019
BUY
$16.17 - $27.38 $2.32 Million - $3.92 Million
143,297 Added 10.67%
1,486,646 $39.9 Million
Q4 2018

Feb 12, 2019
BUY
$14.32 - $22.92 $808,349 - $1.29 Million
56,449 Added 4.39%
1,343,349 $21.7 Million
Q3 2018

Nov 14, 2018
BUY
$13.03 - $21.81 $330,505 - $553,210
25,365 Added 2.01%
1,286,900 $26.7 Million
Q2 2018

Sep 18, 2018
SELL
$15.07 - $22.34 $122,217 - $181,177
-8,110 Reduced 0.64%
1,261,535 $19.3 Million
Q2 2018

Aug 14, 2018
BUY
$15.07 - $22.34 $11.8 Million - $17.4 Million
779,741 Added 159.16%
1,269,645 $19.4 Million
Q1 2018

May 09, 2018
BUY
$22.47 - $32.33 $397,269 - $571,594
17,680 Added 3.74%
489,904 $11 Million
Q4 2017

Feb 14, 2018
BUY
$26.84 - $39.14 $18,546 - $27,045
691 Added 0.15%
472,224 $14.2 Million
Q3 2017

Nov 13, 2017
BUY
$29.49 - $38.37 $13.9 Million - $18.1 Million
471,533
471,533 $17.8 Million

Others Institutions Holding ACAD

# of Institutions
373
Shares Held
162M
Call Options Held
1.46M
Put Options Held
1.09M
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.89B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email